Full Breakdown
Supreme Court Rejects PIL Over Nationwide HPV Vaccination Programme
By Drooid · · How we work
Core Event
On September 10, 2026, the Supreme Court of India dismissed a public-interest litigation (PIL) filed by the Universal Health Organisation (UHO) that challenged the government-run Human Papillomavirus (HPV) vaccination programme for adolescent girls. The petition, presented under Article 32 of the Constitution, sought to halt the school-based component of the rollout and to compel the government to establish a legally compliant informed-consent framework, an adverse-event reporting dashboard, a vaccine-injury compensation scheme, and an independent expert committee. The court recorded that the petitioner had withdrawn the case, and the bench—Chief Justice Surya Kant, Justice Joymalya Bagchi and Justice V. Mohana—refused to entertain further arguments.
Background & Context
The HPV vaccination programme aims to immunise teenage girls against the virus that causes cervical cancer. UHO alleged that the rollout violated constitutional guarantees of informed consent, bodily autonomy, transparency and accountability, citing the absence of written parental consent, lack of a publicly accessible adverse-event-following-immunisation (Adverse Events Following Immunisation (AEFI)) dashboard, and no statutory compensation mechanism. The petition referenced prior Supreme Court jurisprudence on privacy and bodily integrity (e.g., *Justice K.S. Puttaswamy v. Union of India*) and a 2013 Parliamentary Standing Committee report on earlier HPV pilot projects.
Petitioner's Claims and Requested Relief
UHO’s filing listed five specific remedies:
1. Suspension of school-based vaccinations until an informed-consent protocol is in place.
2. Creation of an independent expert committee to review epidemiological data and vaccine safety.
3. Establishment of a real-time public AEFI surveillance dashboard.
4. Notification of a national Vaccine Injury Compensation Scheme.
5. Formulation of a comprehensive Vaccine Consent Framework for minors.
The organisation argued that these measures were necessary to protect constitutional rights while preserving public-health objectives.
Court’s Response and Official Statements
The bench emphasized that ordinary compensation rules would apply in cases of incorrect vaccination and warned that the PIL could jeopardise a vital health initiative. The court also noted that the World Health Organization (WHO) endorses the vaccine, underscoring the programme’s scientific basis.
Verbatim Quote
“No special treatment for one case where adverse effects are seen. Please withdraw the PIL,” — Justice Joymalya Bagchi
